TATYANA MITINA: Open Payments
NPI 1063537561 · WOODLAND HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 41 payments from 8 companies in 2025. Trend: 2023 $524 · 2024 $1,101 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $387 |
| Madrigal Pharmaceuticals | 10 | $265 |
| Janssen Biotech, Inc. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: REZDIFFRA, MAVYRET, LINZESS, CREON, TREMFYA, RINVOQ, VOQUEZNA, ZENPEP.
Industry payments across CA — which companies pay providers there.
